Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

(2017) Dawn I Velligan et al.   Patient Preference and Adherence

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic

(2017) Dominic Pilon et al.   Patient Preference and Adherence

Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach

(2017) Carlos De las Cuevas et al.   Patient Preference and Adherence

Long-Acting Injectable Antipsychotics: Recommendations for Clinicians

(2017) Ashok Malla et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder

(2016) Chi-Shin Wu et al.   JOURNAL OF AFFECTIVE DISORDERS

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

(2016) Christoph U. Correll et al.   JOURNAL OF CLINICAL PSYCHIATRY

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients

(2016) Saínza García et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Guidelines for the use of second-generation long-acting antipsychotics

(2015) Marek Jarema et al.   Psychiatria Polska

Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics

(2015) Onur Baser et al.   JOURNAL OF MEDICAL ECONOMICS

A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder

(2015) Yuan Hwa Chou et al.   Clinical Psychopharmacology and Neuroscience

Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge

(2015) Steven C. Marcus et al.   Journal of Managed Care & Specialty Pharmacy

Time to Discontinuation of Depot and Oral First-Generation Antipsychotics in the Usual Care of Schizophrenia

(2014) Baojin Zhu et al.   PSYCHIATRIC SERVICES

Health Insurance Coverage Among Persons With Schizophrenia in the United States

(2014) Elizabeth Khaykin et al.   PSYCHIATRIC SERVICES

Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

(2013) Steven Potkin et al.   BMC Psychiatry

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

(2013) Pierre Michel Llorca et al.   BMC Psychiatry

Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis

(2013) Marie-Hélène Lafeuille et al.   BMC Psychiatry

Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia

(2013) Noam Y. Kirson et al.   JOURNAL OF CLINICAL PSYCHIATRY

Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder

(2012) Alexandre Duarte Gigante et al.   CNS DRUGS

Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study

(2011) A. J. M. Brnabic et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

(2011) Claudia Leucht et al.   SCHIZOPHRENIA RESEARCH

Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia

(2011) Jaewon Yang et al.   SCHIZOPHRENIA RESEARCH